Life Reinsurer Puts Its Mortality Book Against a Cancer Test the FDA Hasn't Approved
A major US life reinsurer has entered the fray over the FDA's review of a multi-cancer blood test, and it is using its mortality book as evidence.
Read next
Florida’s Push to Privatize Hurricane Risk Is Fueling the Global Cat-Bond Boom
Private insurers absorbing Citizens policies have grown from a marginal presence to a persistent source of catastrophe-bond demand.
